Pregled bibliografske jedinice broj: 978588
Terapija tardivne diskinezije (TD) nastale nakon ukidanja antipsihotične terapije
Terapija tardivne diskinezije (TD) nastale nakon ukidanja antipsihotične terapije // 7th Croatian psychiatric congress, 15th Croatian psychiatric days, Book of abstracts / Jukić, Vlado ; Brečić, Petrana ; Vidović, Domagoj (ur.).
Zagreb: Medicinska naklada, 2018. str. 31-31 (poster, podatak o recenziji nije dostupan, sažetak, stručni)
CROSBI ID: 978588 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Terapija tardivne diskinezije (TD) nastale nakon
ukidanja antipsihotične terapije
(The treatment of tardive dyskinesia emerging after
discontinuation of antipsychotics)
Autori
Kaštelan, Ana ; Petrić, Daniela ; Graovac, Mirjana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
7th Croatian psychiatric congress, 15th Croatian psychiatric days, Book of abstracts
/ Jukić, Vlado ; Brečić, Petrana ; Vidović, Domagoj - Zagreb : Medicinska naklada, 2018, 31-31
ISBN
978-953-176-882-5
Skup
7. hrvatsko – ruski kongres duhovne psihijatrije s međunarodnim sudjelovanjem; 15. hrvatski psihijatrijski dani s međunarodnim sudjelovanjem
Mjesto i datum
Opatija, Hrvatska, 24.10.2018. - 27.10.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
tardivna diskinezija ; antipsihotik
(tardive dyskinesia ; antipsychotic)
Sažetak
Tardive dyskinesia (TD)is a group of delayed- onset movement disorders that are linked to the use of the neuroleptic medications. TD is usually manifested as grimacing, tongue movements, lip smacking or puckering, eye blinking or slow finger movements. It is commonly tied to the prolonged use of the first-generation antipsychotic. For many patients this side-effect is irreversible and has a disabiling impact on everyday life. the exact mechanism of TD remains uncertain and, until recently, there were no approved therapy for TD. Since the end of 2017, FDA approved two medication for TD. Before this we only had potential directions in therapy of TD. It is less known tat TD can emerge after reduction in the dose or discontinuation of an antipsychotic drug. Here we present a case of a young women diagnosed with schizoaffective disorder. she was treated with different atypical antipsychotics during more than three years. Remission was finally achieved after applying high doses of aripiprazol and paliperidone. After discontinuation of the last "atypical" she developed excessive eye blinking which worsened over time. Among recommended treatment options, our patient accepted the treatment with clonazepam and clonazepam did manage to ameliorate the blinking.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka,
Fakultet zdravstvenih studija u Rijeci